Adcock Ingram announces appointment of Brian Joffe as Chairman

February 2014
World Energy News;2/26/2014, p5
The article announces the appointment of Brian Joffe as non-executive Chairman of the Board of Directors and Michael Sacks as an independent non-executive director of the audit committee of the pharmaceutical company Adcock Ingram.


Related Articles

  • Adcock Ingram announces appointment of Brian Joffe as Chairman.  // African Business News;2/26/2014, p10 

    The article reports on personnel changes at Adcock Ingram including the appointment of executive Brian Joffe as non-executive Chairman of the Board of Directors, executive Michael Sacks as an independent non-executive director and Chairman of the Audit Committee and Clifford Raphiri, currently...

  • SIMON' SAYS. Brown, Simon // Finweek;4/11/2013, p20 

    The author discusses the investment approaches and performances of various investment companies including Capitec Bank Holdings, Cipla Medpro, and Bidvest. He mentions that the financial results of Capitec showed strong set of records, except for its cost-to-income ratio of 38% that is...

  • PHARMA: OTHER NEWS TO NOTE.  // BioWorld Today;2/14/2014, Vol. 25 Issue 31, p11 

    The article provides news briefs in the pharmaceutical industry as of February 2014 which include the termination of the agreement between CFR Pharmaceuticals SA and Adcock Ingram, the development of European Gram Negative Antibacterial Engine by pharmaceutical firm Glaxosmithkline plc and...

  • Adcock Ingram delays vote on $1.2bn CFR offer.  // World Energy News;1/9/2014, p2 

    The article reports that a shareholder vote on a 1.2 billion dollars takeover offer from Chile's CFR Pharmaceuticals has been further delayed by South African drugmaker Adcock Ingram. It is mentioned that regulatory approval of shareholder documentation is delaying the vote. It is stated that...

  • South Africa's pharmaceutical manufacturer Adcock Ingram to dispose of loss-making Indian business Cosme Farma.  // African Business News;8/26/2015, p1 

    No abstract available.

  • Ad-izinyosi bought stake in Adcock Ingram.  // African Business News;7/14/2015, p1 

    No abstract available.

  • Adcock offer to shake up industry. Ndweni, Buhie // Finweek;7/18/2013, p30 

    The article offers the insights of several experts in the South African pharmaceutical industry on the bid by Chilean pharmaceutical firm Corporacion Farmaceutica Recalcine (CFR) to purchase Johannesburg Stock Exchange (JSE)-listed Adcock Ingram. Independent healthcare consultant Helen Levy...

  • Appointments and Advancements.  // BioWorld Today;3/25/2011, Vol. 22 Issue 58, p7 

    The article announces executive changes in the pharmaceutical industry, including the proposal of Addex Pharmaceuticals Inc. to add Hoyoung Huh and Oleg Nodelman to the board, the appointment of Adi Hoess as chief commercial officer of Affimed Therapeutics AG, and the appointment of Barry A....

  • Adcock Ingram Appoints CEO.  // South African Pharmaceutical Journal;2014, Vol. 81 Issue 3, p32 

    The article announces the appointment of Kevin Wakeford as Chief Executive Officer of South African health-care company Adcock Ingram.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics